| 000 | 01670 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517182152.0 | ||
| 264 | 0 | _c20180731 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2017.10.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLy, Hoai J | |
| 245 | 0 | 0 |
_aAttenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain. _h[electronic resource] |
| 260 |
_bVaccine _c12 2017 |
||
| 300 |
_a6634-6642 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAfrica _xepidemiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChlorocebus aethiops |
| 650 | 0 | 4 |
_aDisease Outbreaks _xprevention & control |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aReverse Genetics _xmethods |
| 650 | 0 | 4 |
_aRift Valley Fever _xepidemiology |
| 650 | 0 | 4 |
_aRift Valley fever virus _xgenetics |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 650 | 0 | 4 | _aVero Cells |
| 650 | 0 | 4 |
_aViral Nonstructural Proteins _ximmunology |
| 650 | 0 | 4 |
_aViral Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aVirulence |
| 700 | 1 | _aNishiyama, Shoko | |
| 700 | 1 | _aLokugamage, Nandadeva | |
| 700 | 1 | _aSmith, Jennifer K | |
| 700 | 1 | _aZhang, Lihong | |
| 700 | 1 | _aPerez, David | |
| 700 | 1 | _aJuelich, Terry L | |
| 700 | 1 | _aFreiberg, Alexander N | |
| 700 | 1 | _aIkegami, Tetsuro | |
| 773 | 0 |
_tVaccine _gvol. 35 _gno. 48 Pt B _gp. 6634-6642 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2017.10.036 _zAvailable from publisher's website |
| 999 |
_c27713654 _d27713654 |
||